The price of a box of Afatinib and purchasing reference information in various regions

Afatinib (Afatinib) is a targeted therapy drug mainly used to treat patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). The drug irreversibly inhibits the tyrosine kinase activity of EGFR and its family receptors, blocking tumor cell signaling pathways, thereby inhibiting tumor growth. Due to its high target specificity, afatinib has shown good clinical efficacy in patients with EGFR sensitive mutations.

in the country, afatinib has been approved for marketing and included in the medical insurance directory. According to market information in 2025, the price of the original drug is approximately 2,300 yuan per box (40mg×7 tablets). After the patient is reimbursed by medical insurance, the actual payment amount will be reduced. For specific reimbursement ratios and fees, please consult local hospitals and pharmacies. Medical insurance coverage reduces the financial burden on patients while ensuring the regularity and safety of medication.

In overseas markets, the price of afatinib varies greatly. The price of the original version in India is about more than 5,000 yuan, while the generic version is more affordable, including the Indian, Laos and Bangladesh versions, with prices ranging from a few hundred to more than 2,000 yuan. It should be noted that although the price is low, the ingredients of generic drugs are basically the same as those of the original drugs, and the efficacy can remain similar in most cases. Patients can choose a suitable source of medicines based on their own circumstances and economic conditions.

When purchasing and using afatinib, patients should ensure that the source of the drug is formal and reliable, and avoid purchasing through unofficial channels. It is recommended to obtain it through hospital pharmacies, certified drug e-commerce or international drug importers, and use it under the guidance of a doctor to ensure therapeutic effect and safety. At the same time, patients should also pay attention to the storage conditions and medication cycle of the medicine to avoid affecting the efficacy due to improper storage or self-adjustment of the dosage.

Reference materials:https://www.drugs.com/